Artivion, Inc. Share Price

Equities

AORT

US2289031005

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
20.57 USD +1.48% Intraday chart for Artivion, Inc. +2.70% +15.04%
Sales 2024 * 388M 32.37B Sales 2025 * 427M 35.64B Capitalization 858M 71.57B
Net income 2024 * -10M -834M Net income 2025 * 7M 584M EV / Sales 2024 * 2.21 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.01 x
P/E ratio 2024 *
-70 x
P/E ratio 2025 *
168 x
Employees 1,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 85.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.48%
1 week+2.70%
Current month-2.79%
1 month-2.79%
3 months+22.22%
6 months+66.83%
Current year+15.04%
More quotes
1 week
19.70
Extreme 19.7
21.18
1 month
19.53
Extreme 19.525
21.90
Current year
16.48
Extreme 16.4842
21.90
1 year
12.16
Extreme 12.1582
21.90
3 years
9.64
Extreme 9.64
32.34
5 years
9.64
Extreme 9.64
33.00
10 years
8.40
Extreme 8.4
36.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 02/14/02
Director of Finance/CFO 51 04/12
Chief Operating Officer 42 01/23/01
Members of the board TitleAgeSince
Director/Board Member 59 01/12/01
Director/Board Member 69 01/03/01
Director/Board Member 64 01/03/01
More insiders
Date Price Change Volume
26/24/26 20.57 +1.48% 85,902
25/24/25 20.27 -3.11% 190,588
24/24/24 20.92 +0.67% 172,979
23/24/23 20.78 +2.26% 133,016
22/24/22 20.32 +1.45% 122,183

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
20.57 USD
Average target price
25.15 USD
Spread / Average Target
+22.27%
Consensus